1. Clinical Trials for Antihypertensive Drugs: Implications of Introducing Telemetric Self-measured Blood Pressure

   • Volker Möckel
   • Aditya Bahl
   • Albert Kandra

   Clinical Trials 30 December 2009 Pages: 233 - 241

2. A Robust Methodological Approach for Replacing Global Electronic Document Management

   • Dimitri Stamatiadis
   • Steve Scribner

   Drug Information 30 December 2009 Pages: 243 - 251

3. Pharmaceutical Product Liabilities: A Review of Current Status and Future Trends

   • Pol F. Boudes

   Drug Information 30 December 2009 Pages: 253 - 261

4. Assessment of Customer Satisfaction with Verbal Responses Provided by a Pharmaceutical Company’s Third-Party Medical Information Call Center

   • Piper Black
   • Christi Marsh
   • Laurel Ashworth

   Drug Information 30 December 2009 Pages: 263 - 271

5. Generic versus Branded Pharmaceutical Strategic Considerations: An Irish Focus with Global Perspective

   • Kara Daly

   Drug Information 30 December 2009 Pages: 273 - 286

6. Development of a Content Uniformity Test Suitable for Sample Sizes between 30 and 100

   • Myron Diener
   • Greg Larner
   • Soren Andersen

   Biostatistics 30 December 2009 Pages: 287 - 298

7. Editor’s Note

   • Herng-Der Chern

   Good Regulatory Science in Asia/Pacific: Part 2 30 December 2009 Pages: 299 - 300

8. An Experimental Model of Regulatory Science in Asia: Center for Drug Evaluation in Taiwan

   • Herng-Der Chern
   • Churn-Shiouh Gau
   • Chi-Chou Liao

   Good Regulatory Science in Asia/Pacific: Part 2 30 December 2009 Pages: 301 - 304

9. APEC Pharmaceutical Evaluation Report (PER) Scheme: A Regional Solution for Global Drug Development

   • Chih-Hwa Lin
   • Bing Bing Lin
   • Herng-Der Chern

   Good Regulatory Science in Asia/Pacific: Part 2 30 December 2009 Pages: 305 - 309

10. The Critical Path Program in Taiwan

    • Bing Bing Lin
    • Chih-Hwa Lin
    • Herng-Der Chern

    Good Regulatory Science in Asia/Pacific: Part 2 30 December 2009 Pages: 311 - 317

11. A Proposal for a Parallel Submission Process for New Drug Applications and Health Technology Assessment in Taiwan: A Win-Win Solution

    • Yen-Huei Tarn
    • Herng-Der Chern

    Good Regulatory Science in Asia/Pacific: Part 2 30 December 2009 Pages: 319 - 323

12. Harmonizing East Asia: The Evolution of DIA in Japan and Its Impact on East Asia

    • Kiichiro Tsutani
    • Wen-Hua Kuo
    • Takatoshi Sato

    Good Regulatory Science in Asia/Pacific: Part 2 30 December 2009 Pages: 325 - 338

13. Industry Efforts on Simultaneous Global Development

    • Jean-Louis Saillot
    • Mark Paxton

    Good Regulatory Science in Asia/Pacific: Part 2 30 December 2009 Pages: 339 - 347

14. Emerging Markets and Emerging Agencies: A Comparative Study of How Key Regulatory Agencies in Asia, Latin America, the Middle East, and Africa are Developing Regulatory Processes and Review Models for New Medicinal Products

    • Neil McAuslane
    • Margaret Cone
    • Stuart Walker

    Good Regulatory Science in Asia/Pacific: Part 2 30 December 2009 Pages: 349 - 359

15. National Center of Excellence for Clinical Trials and Research at National Taiwan University Hospital

    • Chia-Chi Lin
    • Chih-Hsin Yang
    • Hong-Nerng Ho

    Good Regulatory Science in Asia/Pacific: Part 2 30 December 2009 Pages: 361 - 363

16. Nurturing the Clinical Research Leaders of Tomorrow

    • Feng-Pin Chuang
    • Wing-Kai Chan
    • Herng-Der Chern

    Good Regulatory Science in Asia/Pacific: Part 2 30 December 2009 Pages: 365 - 369

17. An Overview of Bridging Study Evaluation in Taiwan

    • Li-Li Su
    • Herng-Der Chern
    • Min-Shung Lin

    Good Regulatory Science in Asia/Pacific: Part 2 30 December 2009 Pages: 371 - 376

18. 8th Middle East Regulatory Conference

    • Florence Roizard

    Proceedings 30 December 2009 Pages: 377 - 384